Related Experiment Video
Updated: Aug 16, 2026

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
Published on: November 30, 2016
Standards of Reporting Kampo Products (STORK) in research articles
Yoshiharu Motoo1,2, Takashi Hakamatsuka1,3, Nobuo Kawahara1,4
1Committee for Evidence-based Medicine, Japan Society for Oriental Medicine, Tokyo, Japan.
Abstract:
There had been no standardized rules for citing ethical Kampo products used in clinical trials in journal articles. Although the name of a Kampo manufacturer was described in 77.9% of research articles, the name and ratios of crude drug components of Kampo formulas were not described in 77.5% of these papers. Considering the importance of proper characterization of interventions in the Consolidated Standards of Reporting Trials (CONSORT) checklist, we hereby propose the use of the Standards of Reporting Kampo Products (STORK) website, http://mpdb.nibiohn.go.jp/stork, as a reference for Kampo products. This will provide an official source on the internet for verified information on individual Kampo formulations for citation purposes in clinical research articles.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment

